SOPHIM's acquisition of Novastell represents a strategic move aimed at furthering the company's expansion. With a strong presence in the cosmetics and pharmaceutical sectors, SOPHIM is pursuing its growth with this acquisition. A merger marking a new stage in SOPHIM's diversification. Through this integration, SOPHIM raises its consolidated sales for 2023 to 36 million euros, with a total workforce of 80, while asserting its status as an integrated and autonomous player.
"Synergies between cosmetics and nutraceuticals are increasingly numerous. This acquisition will enable us to accelerate our growth and bring new products to market more quickly" says Jacques Margnat, Chairman and CEO of SOPHIM.
"This acquisition is of particular importance given the convergence of our business models: Novastell, as Sophim, valorises byproducts from the edible oil industry to create ingredients for the nutraceutical industry. This match not only reflects our shared values, but also responds to market dynamics, reinforcing the strategic relevance of our merger" adds Alexis Margnat, Managing Director of SOPHIM.
